Research shows positive results in cannabis spray for cancer patients

66 0

An advanced form of cannabis delivery is proving beneficial in the fight against cancer

Data published in the journal PLOS One claims that a proprietary cannabis spray containing equal proportions of plant-derived tetrahydrocannabinol (THC) and cannabidiol (CBD) has been helpful in undermining discomfort in terminal cancer patients with refractory pain. For some time now, research has been suggesting cannabis spray as an effective alternative in combating certain diseases. It seems that cancer was not left off that list.

A novel water-soluble orobuccal nanoparticle spray containing 2.5 mg of THC and 2.5 mg of CBD appears to be coming to help a lot of oncological patients. A group of Australian researchers took it upon themselves to evaluate the efficacy and safety of this product in a cohort of patients with advanced cancer and intractable pain.

According to the specialists, the marijuana dosage was linked to improvements in pain relief among each of the patients. This was especially evident in patients with bone metastases, who reported quite a high level of relief.

While some patients experienced drowsiness after treatment, no serious adverse effects were reported. Emotional well-being and improvements in appetite were other benefits reported by patients following the use of this spray.

“This study demonstrated that the administration of the investigational cannabis-based medicine was generally safe and tolerated in a short-term exposure in a cohort of patients with advanced incurable cancers with controlled pain or intractable pain despite opioid treatment,” the authors concluded. “There was a reduction in pain overall for the study cohort of 12 percent by the end of the treatment phase. … [This] cannabis-based medicine … is of significant clinical interest given that this formulation was a self-titrated medicine, that showed preliminary analgesic efficacy in a subgroup of patients.”